Back
CTO Realty Growth 10K Form
Sell
30
CTO
CTO Realty Growth
Last Price:
$17.23
Seasonality Move:
-0.44%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | CTO/CTO Realty Growth Quarterly |
2023-10-26 | 10Q | CTO/CTO Realty Growth Quarterly |
2023-07-27 | 10Q | CTO/CTO Realty Growth Quarterly |
2023-04-27 | 10Q | CTO/CTO Realty Growth Quarterly |
2022-10-27 | 10Q | CTO/CTO Realty Growth Quarterly |
2022-07-28 | 10Q | CTO/CTO Realty Growth Quarterly |
Receive CTO News And Ratings
See the #1 stock for the next 7 days that we like better than CTO
CTO Financial Statistics
Sales & Book Value
Annual Sales: | $124.5M |
---|---|
Cash Flow: | $10.3M |
Price / Cash Flow: | 7.02 |
Annual Sales: | $18.65 |
Price / Book: | 0.96 |
Profitability
EPS (TTM): | -0.55000 |
---|---|
Net Income (TTM): | $-5.5M |
Gross Margin: | $91.3M |
Return on Equity: | -1.01% |
Return on Assets: | -0.49% |
CTO Realty Growth Earnings Forecast
Key CTO Realty Growth Financial Ratios
-
The Gross Profit Margin over the past 41 years for CTO is 73.32%.
-
The Selling, General & Administrative Expenses for CTO have been equal to 13.07% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of CTO is -1.58% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 19 years.
CTO Realty Growth Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Diversified REITs |
Sector: | Real Estate |
Current Symbol: | CTO |
CUSIP: | 210226 |
Website: | ctoreit.com |
Debt
Debt-to-Equity Ratio: | 1.01 |
---|---|
Current Ratio: | 2.53 |
Quick Ratio: | 2.43 |
Price-to-Earnings
Trailing P/E Ratio: | 633.67 |
---|---|
Forward P/E Ratio: | 55.06 |
CTO Technical Analysis vs Fundamental Analysis
Sell
30
CTO Realty Growth (CTO)
is a Sell
Is CTO Realty Growth a Buy or a Sell?
-
CTO Realty Growth stock is rated a SellThe current CTO Realty Growth [CTO] share price is $17.24. The Score for CTO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.